News
Author:Shweta Raskar, Business Development Specialist, Prophecy Market InsightsIntroductionThe Multi-Cancer Early Detection (MCED) Market is witnessing an unprecedented surge as diagnostic ...
TSRL, Inc., a preclinical CRO specializing in testing services and early-stage development strategies, announced today the ...
Advarra, the market leader in regulatory reviews and a leading provider of clinical research technology, today announced a major expansion of its Study Collaboration solution, the only study startup ...
Biocair Announces Rapid APAC Expansion with New Office in Shanghai4 August 2025, Cambridge, UK – Biocair, an established global leader in life science logistics, today announces the further expansion ...
EVERSANA Announces Development of End-to-End AI-Powered Life Sciences Marketing Agency Built on Google Cloud Technology CHICAGO – August 4, 2025 - EVERSANA®, a leading provider of commercialization ...
Modular Medical intends to deploy the MODD1 on a larger number of clinicians in mid August SAN DIEGO, CA / ACCESS Newswire / August 6, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or ...
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of DirectorsBuchanan is former CFO and COO of Silk Road Medical, where he successfully scaled a growth-stage medical device ...
Press ReleaseIB [email protected] ScaleReady Announces a G-Rex® Grant has been awarded to Sidra Medicine ST. PAUL, Minn., Aug. 5, 2025 - ScaleReady, in collaboration with Wilson ...
Microbot Medical® Receives Non-Dilutive Grant to Enhance Operational CapabilitiesStrengthens Balance Sheet and Continues Commercialization Readiness Plans for the LIBERTY® System as it Nears FDA ...
Author:Shweta Raskar, Business Development Specialist, Prophecy Market InsightsIntroductionThe Europe Legal Cannabis Market ...
Global Proteomics Market is estimated to be valued at USD 123.1 Billion by 2035, with an exponential growth of 12.55% in the ...
Senolytic Supplements Market to Reach $350 Million by 2025, Poised for 15% CAGR Through 2032 Driven by growing focus on healthy aging and breakthroughs in cellular senescence-targeted therapies The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results